Survival time of ECMO circuits on and off bleeding protocol: Is there a higher risk of circuit clotting?

European Journal of Pediatric Surgery

Volumn 21, Issue 1, 2011, Pages 30-32

  Muensterer, O J ^a   Laney, D ^a   Georgeson, K E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

bleeding protocol; circuit life; extracorporeal membrane oxygenation; thrombosis

Indexed keywords

AMINOCAPROIC ACID;

ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CANNULATION; COMPRESSION; CONGENITAL DIAPHRAGM HERNIA; EXTRACORPOREAL OXYGENATION; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HUMAN; KAPLAN MEIER METHOD; LIVER HEMORRHAGE; LOG RANK TEST; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MECONIUM ASPIRATION; MEDIASTINUM; NEONATAL RESPIRATORY DISTRESS SYNDROME; PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPSIS; SURGICAL TECHNIQUE; SURVIVAL TIME; THORAX COMPRESSION; THROMBOSIS; TREATMENT INDICATION; TREATMENT PLANNING;

AMINOCAPROIC ACIDS; BLOOD COAGULATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMORRHAGE; HUMANS; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 79951556087     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0030-1267242     Document Type: Article

References (10)

1. Extracorporeal Life Support Organization (ELSO). General Guidelines for all ECLS Cases. Available online at: http://www.elso.med.umich.edu/WordForms/ ELSO%20Guidelines%20General%20All%20ECLS%20Version1.1.pdf last accessed 16 August 2010
2. Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal (Pubitemid 30116981)
3. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 2009 13 154-175
4. Wilson JM, Bower LK, Fackler JC, et al. Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatr Surg 1993 28 536-540
5. Downard CD, Betit P, Chang RW, et al. Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. J Pediatr Surg 2003 38 1212-1216 (Pubitemid 37048044)
6. Sell LL, Cullen ML, Whittlesey GC, et al. Hemorrhagic complications during extracorporeal membrane oxygenation: prevention and treatment. J Pediatr Surg 1986 21 1087-1091 (Pubitemid 17187896)
7. Reed RC, Rutledge JC. Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric ECMO nonsurvivors. Pediatr Dev Pathol 2010 Jan 19. [Epub ahead of print] PMID: 20085498
8. Chalwin RP, Tiruvoipati R, Peek GJ. Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 2008 34 685-686
9. Graves DF, Chernin JM, Kurusz M, et al. Anticoagulation practices during neonatal extracorporeal membrane oxygenation: survey results. Perfusion 1996 11 461-466 (Pubitemid 27007208)
10. Baird CW, Zurakowski D, Robinson B, et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. Ann Thorac Surg 2007 83 912-919